{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:13:25Z","timestamp":1749096805092,"version":"3.41.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101089287","101089287"],"award-info":[{"award-number":["101089287","101089287"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>When genes are translated into proteins, mutations in the gene sequence can lead to changes in protein structure and function as well as in the interactions between proteins. These changes can disrupt cell function and contribute to the development of tumors. In this study, we introduce a novel approach based on graph neural networks that jointly considers genetic mutations and protein interactions for cancer prediction. We use DNA mutations in whole exome sequencing data and construct a heterogeneous graph in which patients and proteins are represented as nodes and protein-protein interactions as edges. Furthermore, patient nodes are connected to protein nodes based on mutations in the patient\u2019s DNA. Each patient node is represented by a feature vector derived from the mutations in specific genes. The feature values are calculated using a weighting scheme inspired by information retrieval, where whole genomes are treated as documents and mutations as words within these documents. The weighting of each gene, determined by its mutations, reflects its contribution to disease development. The patient nodes are updated by both mutations and protein interactions within our noval heterogeneous graph structure. Since the effects of each mutation on disease development are different, we processed the input graph with attention-based graph neural networks.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We compiled a dataset from the UKBiobank consisting of patients with a cancer diagnosis as the case group and those without a cancer diagnosis as the control group. We evaluated our approach for the four most common cancer types, which are breast, prostate, lung and colon cancer, and showed that the proposed framework effectively discriminates between case and control groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The results indicate that our proposed graph structure and node updating strategy improve cancer classification performance. Additionally, we extended our system with an explainer that identifies a list of causal genes which are effective in the model\u2019s cancer diagnosis predictions. Notably, some of these genes have already been studied in cancer research, demonstrating the system\u2019s ability to recognize causal genes for the selected cancer types and make predictions based on them.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12859-025-06133-0","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:32:29Z","timestamp":1749040349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GNNMutation: a heterogeneous graph-based framework for cancer detection"],"prefix":"10.1186","volume":"26","author":[{"given":"Nuriye \u00d6zlem","family":"\u00d6zcan \u015eim\u015fek","sequence":"first","affiliation":[]},{"given":"Arzucan","family":"\u00d6zg\u00fcr","sequence":"additional","affiliation":[]},{"given":"Fikret","family":"G\u00fcrgen","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"6133_CR1","unstructured":"The national cancer institute: (NCI). https:\/\/www.cancer.gov\/"},{"key":"6133_CR2","doi-asserted-by":"crossref","unstructured":"Ramirez R, Chiu Y-C, Hererra A, Mostavi M, Ramirez J, Chen Y, Huang Y, Jin Y-F. Classification of cancer types using graph convolutional neural networks. In: Frontiers of Physics 2020.","DOI":"10.3389\/fphy.2020.00203"},{"key":"6133_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s42256-021-00325-y","volume":"3","author":"R Schulte-Sasse","year":"2021","unstructured":"Schulte-Sasse R, Budach S, Hnisz D, Marsico A. Integration of multiomics data with graph convolutional networks to identify new cancer genes and their associated molecular mechanisms. Nat Mach Intell. 2021;3:513\u201326.","journal-title":"Nat Mach Intell"},{"key":"6133_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/bioinformatics\/btac478","volume":"38","author":"B Pfeifer","year":"2022","unstructured":"Pfeifer B, Secic A, Saranti A, Holzinger A. Gnn-subnet: disease subnetwork detection with explainable graph neural networks. Bioinformatics. 2022;38:120\u20136.","journal-title":"Bioinformatics"},{"key":"6133_CR5","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.gpb.2022.11.004","volume":"20","author":"S Zhang","year":"2022","unstructured":"Zhang S, Xu J, Zhang T. Dgmp: identifying cancer driver genes by jointing dgcn and mlp from multi-omics genomic data. Genomics, Proteomics Bioinf. 2022;20:928\u201338.","journal-title":"Genomics, Proteomics Bioinf"},{"issue":"1","key":"6133_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12859-023-05140-3","volume":"24","author":"W Peng","year":"2023","unstructured":"Peng W, Wu R, Dai W, Yu N. Identifying cancer driver genes based on multi-view heterogeneous graph convolutional network and self-attention mechanism. BMC Bioinf. 2023;24(1):16.","journal-title":"BMC Bioinf."},{"issue":"1","key":"6133_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12911-023-02173-9","volume":"23","author":"Y Zhong","year":"2023","unstructured":"Zhong Y, Peng Y, Lin Y, Chen D, Zhang H, Zheng W, Chen Y, Wu C. Modilm: towards better complex diseases classification using a novel multi-omics data integration learning model. BMC Med Inf Decis Making. 2023;23(1):82.","journal-title":"BMC Med Inf Decis Making."},{"issue":"1","key":"6133_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12859-023-05622-4","volume":"25","author":"B Li","year":"2024","unstructured":"Li B, Nabavi S. A multimodal graph neural network framework for cancer molecular subtype classification. BMC Bioinf. 2024;25(1):27.","journal-title":"BMC Bioinf."},{"issue":"11","key":"6133_CR9","doi-asserted-by":"publisher","first-page":"btad643","DOI":"10.1093\/bioinformatics\/btad643","volume":"39","author":"M Chatzianastasis","year":"2023","unstructured":"Chatzianastasis M, Vazirgiannis M, Zhang Z. Explainable multilayer graph neural network for cancer gene prediction. Bioinformatics. 2023;39(11):btad643.","journal-title":"Bioinformatics."},{"key":"6133_CR10","doi-asserted-by":"publisher","first-page":"1363896","DOI":"10.3389\/fgene.2024.1363896","volume":"15","author":"Y Ren","year":"2024","unstructured":"Ren Y, Gao Y, Du W, Qiao W, Li W, Yang Q, Liang Y, Li G. Classifying breast cancer using multi-view graph neural network based on multi-omics data. Front Genet. 2024;15:1363896.","journal-title":"Front Genet."},{"key":"6133_CR11","doi-asserted-by":"crossref","unstructured":"Rosa D, Pellicani A, Pio G, D\u2019Elia D, Ceci M. Exploiting microrna expression data for the diagnosis of disease conditions and the discovery of novel biomarkers. In: International syposium on methodologies for intelligent systems, 2024;77\u201386","DOI":"10.1007\/978-3-031-62700-2_8"},{"key":"6133_CR12","doi-asserted-by":"publisher","first-page":"1466825","DOI":"10.3389\/fgene.2024.1466825","volume":"15","author":"J Liu","year":"2024","unstructured":"Liu J, Xue X, Wen P, Song Q, Yao J, Ge S. Multi-fusion strategy network-guided cancer subtypes discovering based on multi-omics data. Front Genet. 2024;15:1466825.","journal-title":"Front Genet."},{"key":"6133_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.806842","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Ma J, Leng L, Han M, Li M, He F, Zhu Y-p. Mogcn: a multi-omics integration method based on graph convolutional network for cancer subtype analysis. Front Genet. 2022;13: 806842.","journal-title":"Front Genet."},{"issue":"3","key":"6133_CR14","doi-asserted-by":"publisher","first-page":"080","DOI":"10.1093\/bib\/bbae080","volume":"25","author":"Z Xu","year":"2024","unstructured":"Xu Z, Liao H, Huang L, Chen Q, Lan W, Li S. Ibpgnet: lung adenocarcinoma recurrence prediction based on neural network interpretability. Brief Bioinf. 2024;25(3):080.","journal-title":"Brief Bioinf."},{"key":"6133_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-024-07769-3","volume":"633","author":"L Nunes","year":"2024","unstructured":"Nunes L, Li F, Wu M, Luo T, Hammarstrom K, Torell E, Ljuslinder I, Mezheyeuski A, Edqvist P-HD, Lofgren-Burstrom A, Zingmark C, Edin S, Larsson C, Mathot L, Osterman E, Osterlund E, Ljungstrom V, Neves I, Yacoub N, Gudnadottir U, Birgisson H, Enblad M, Ponten F, Palmqvist R, Xu X, Uhlen M, Wu K, Glimelius B, Lin C, Sjoblom T. Prognostic genome and transcriptome signatures in colorectal cancers. Nature. 2024;633:137\u201346.","journal-title":"Nature"},{"key":"6133_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-024-07747-9","volume":"633","author":"AJ Cornish","year":"2024","unstructured":"Cornish AJ, Gruber AJ, Kinnersley B, Chubb D, Frangou A, Caravagna G, Noyvert B, Lakatos E, Wood HM, Thorn S, Culliford R, Arnedo-Pac C, Househam J, Cross W, Sud A, Law PJ, Leathlobhair MN, Hawari A, Woolley C, Sherwood K, Feeley N, G\u00fcl G, Fernandez-Tajes J, Zapata L, Alexandrov LB, Murugaesu N, Sosinsky A, Mitchell J, L\u00f3pez-Bigas N, Quirke P, Church DN, Tomlinson IPM, Sottoriva A, Graham TA, Wedge DC, Houlston RS. The genomic landscape of 2,023 colorectal cancers. Nature. 2024;633:127\u201336.","journal-title":"Nature"},{"key":"6133_CR17","doi-asserted-by":"crossref","unstructured":"Braun P, Gingras A-C. History of protein-protein interactions: From egg?white to complex networks. PROTEOMICS. 2012;12.","DOI":"10.1002\/pmic.201100563"},{"issue":"5","key":"6133_CR18","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.3390\/ijms25052788","volume":"25","author":"RB Tanvir","year":"2024","unstructured":"Tanvir RB, Islam MM, Sobhan M, Luo D, Mondal AM. Mogat: a multi-omics integration framework using graph attention networks for cancer subtype prediction. Int J Mol Sci. 2024;25(5):2788.","journal-title":"Int J Mol Sci."},{"key":"6133_CR19","doi-asserted-by":"publisher","first-page":"1378809","DOI":"10.3389\/fgene.2024.1378809","volume":"15","author":"G Zhang","year":"2024","unstructured":"Zhang G, Ma C, Yan C, Luo H, Wang J, Liang W, Luo J. Msfn: a multi-omics stacked fusion network for breast cancer survival prediction. Front Genet. 2024;15:1378809.","journal-title":"Front Genet."},{"issue":"19","key":"6133_CR20","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.3390\/diagnostics14192178","volume":"14","author":"MK Elbashir","year":"2024","unstructured":"Elbashir MK, Almotilag A, Mahmood MA, Mohammed M. Enhancing non-small cell lung cancer survival prediction through multi-omics integration using graph attention network. Diagnostics. 2024;14(19):2178.","journal-title":"Diagnostics."},{"key":"6133_CR21","unstructured":"UKBiobank: (UKBiobank). https:\/\/www.ukbiobank.ac.uk\/"},{"key":"6133_CR22","unstructured":"American Cancer Society: (ACS). https:\/\/www.cancer.org\/"},{"key":"6133_CR23","unstructured":"VCF Specification: (2022). https:\/\/samtools.github.io\/hts-specs\/VCFv4.2.pdf"},{"key":"6133_CR24","unstructured":"Hallmark: (Hallmark). https:\/\/www.gsea-msigdb.org\/gsea\/msigdb\/collections.jsp\/"},{"key":"6133_CR25","unstructured":"StringDB: (StringDB). https:\/\/string-db.org\/"},{"key":"6133_CR26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12859-019-2868-4","volume":"20","author":"NO Ozcan Simsek","year":"2019","unstructured":"Ozcan Simsek NO, Ozgur A, Gurgen F. Statistical representation models for mutation information within genomic data. BMC Bioinf. 2019;20:324.","journal-title":"BMC Bioinf"},{"key":"6133_CR27","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1109\/TPAMI.2008.110","volume":"31","author":"M Lan","year":"2009","unstructured":"Lan M, Tan CL, Su J, Lu Y. Supervised and traditional term weighting methods for automatic text categorization. IEEE Trans Pattern Anal Mach Intell. 2009;31:721\u201335.","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"issue":"1","key":"6133_CR28","doi-asserted-by":"publisher","first-page":"10715","DOI":"10.1038\/ncomms10715","volume":"7","author":"K Gumireddy","year":"2016","unstructured":"Gumireddy K, Li A, Kossenkov AV, Sakurai M, Yan J, Li Y, Xu H, Wang J, Zhang PJL, Zhang L, Showe LC, Nishikura K, Huang Q. The mrna-edited form of gabra3 suppresses gabra3-mediated akt activation and breast cancer metastasis. Nat Commun. 2016;7(1):10715.","journal-title":"Nat Commun."},{"key":"6133_CR29","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1111\/jcmm.16706","volume":"25","author":"Y Chen","year":"2021","unstructured":"Chen Y, Jia Y, Mao M, Gu Y, Xu C, Yang J, Hu W-X, Shen J, Hu D, Chen C, Li Z, Chen L, Ruan J, Shen P, Zhou J, Wei Q, Wang L. Plac8 promotes adriamycin resistance via blocking autophagy in breast cancer. J Cell Mol Med. 2021;25:6948\u201362.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"6133_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057095","volume":"8","author":"S Saini","year":"2013","unstructured":"Saini S, Jagadish N, Gupta A, Bhatnagar A, Suri A. A novel cancer testis antigen, a-kinase anchor protein 4 (akap4) is a potential biomarker for breast cancer. PLoS ONE. 2013;8(2): e57095.","journal-title":"PLoS ONE."},{"key":"6133_CR31","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0306-4573(00)00015-7","volume":"36","author":"KS Jones","year":"2000","unstructured":"Jones KS, Walker S, Robertson SE. A probabilistic model of information retrieval: development and comparative experiments - part 1. Inf Process Manag. 2000;36:779\u2013808.","journal-title":"Inf Process Manag"},{"key":"6133_CR32","unstructured":"PyG: (PyG). https:\/\/pyg.org\/"},{"key":"6133_CR33","unstructured":"Velickovic P, Cucurull G, Casanova A, Romero A, Lio\u2019 P, Bengio Y. Graph attention networks. 2017. arxiv: abs\/1710.10903"},{"key":"6133_CR34","unstructured":"Captum: (Captum). https:\/\/captum.ai\/"},{"key":"6133_CR35","unstructured":"Sundararajan M, Taly A, Yan Q. Axiomatic attribution for deep networks. In: international conference on machine learning 2017."},{"issue":"10","key":"6133_CR36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.cancergen.2012.08.001","volume":"205","author":"GE Theodoropoulos","year":"2012","unstructured":"Theodoropoulos GE, Michalopoulos NV, Pantou MP, Kontogianni P, Gazouli M, Karantanos T, Lymperi M, Zografos GC. Caspase 9 promoter polymorphisms confer increased susceptibility to breast cancer. Cancer Genet. 2012;205(10):508\u201312.","journal-title":"Cancer Genet"},{"key":"6133_CR37","first-page":"1043445","volume":"1","author":"M Zhang","year":"2022","unstructured":"Zhang M, Wu K, Wang M, Bai F, Chen H. 2021 Casp9 as a prognostic biomarker and promising drug target plays a pivotal role in inflammatory breast cancer. Int J Anal Chem. 2022;1:1043445.","journal-title":"Int J Anal Chem"},{"key":"6133_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1158\/1541-7786.MCR-20-1044","volume":"20","author":"D Kumar","year":"2021","unstructured":"Kumar D, Patel SA, Khan R, Chawla S, Mohapatra N, Dixit M. Iq motif-containing gtpase-activating protein 2 inhibits breast cancer angiogenesis by suppressing vegfr2\u2013akt signaling. Mol Cancer Res. 2021;20:77\u201391.","journal-title":"Mol Cancer Res"},{"issue":"4","key":"6133_CR39","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41419-021-03673-0","volume":"12","author":"D Kumar","year":"2021","unstructured":"Kumar D, Patel SA, Hassan MK, Mohapatra N, Pattanaik N, Dixit M. Reduced iqgap2 expression promotes emt and inhibits apoptosis by modulating the mek-erk and p38 signaling in breast cancer irrespective of er status. Cell Death Dis. 2021;12(4):389.","journal-title":"Cell Death Dis."},{"issue":"2","key":"6133_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056817","volume":"8","author":"A Turner","year":"2013","unstructured":"Turner A, Li L-C, Pilli T, Qian L, Wiley EL, Setty S, Christov KT, Ganesh L, Maker AV, Li P, Kanteti P, Gupta TKD, Prabhakar BS. Madd knock-down enhances doxorubicin and trail induced apoptosis in breast cancer cells. PLoS ONE. 2013;8(2): e56817.","journal-title":"PLoS ONE."},{"issue":"1","key":"6133_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13058-024-01767-z","volume":"26","author":"Z-M Peng","year":"2024","unstructured":"Peng Z-M, Han X, Wang T, Li J-J, Yang C-X, Tou F-F, Zhang Z. Pfkp deubiquitination and stabilization by usp5 activate aerobic glycolysis to promote triple-negative breast cancer progression. Breast Cancer Res. 2024;26(1):10.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"6133_CR42","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41420-023-01450-w","volume":"9","author":"Y Tian","year":"2023","unstructured":"Tian Y, Zhang P, Mou Y, Yang W, Zhang J, Li Q, Dou X. Silencing notch4 promotes tumorigenesis and inhibits metastasis of triple-negative breast cancer via nanog and cdc42. Cell Death Discov. 2023;9(1):148.","journal-title":"Cell Death Discov."},{"key":"6133_CR43","first-page":"154","volume":"14","author":"M Eini","year":"2022","unstructured":"Eini M, Parsi S, Barati M, Bahramali G, Zarei MA, Kiani J, Azarnezhad A, Hosseini A. Bioinformatic investigation of micro rna-802 target genes, protein networks, and its potential prognostic value in breast cancer. Avicenna J Med Biotechnol. 2022;14:154\u201364.","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"6133_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-019-1236-7","volume":"21","author":"L Wan","year":"2019","unstructured":"Wan L, Liu T, Hong Z, Pan Y, Sizemore ST, Zhang J, Ma Z. Nedd4 expression is associated with breast cancer progression and is predictive of a poor prognosis. Breast Cancer Res: BCR. 2019;21:1\u201316.","journal-title":"Breast Cancer Res: BCR."},{"issue":"2","key":"6133_CR45","doi-asserted-by":"publisher","first-page":"526","DOI":"10.62347\/DDII2115","volume":"14","author":"H Deng","year":"2024","unstructured":"Deng H, Wen C, Jiang S, Yu Y, Zhao J, Zhang B. Single-cell analysis reveals one cancer-associated fibroblasts subtype linked to metastasis in breast cancer: Mxra5 as a potential novel marker for prognosis. Am J Cancer Res. 2024;14(2):526\u201344.","journal-title":"Am J Cancer Res"},{"key":"6133_CR46","doi-asserted-by":"publisher","first-page":"10525","DOI":"10.1111\/jcmm.15668","volume":"24","author":"Q-W Liu","year":"2020","unstructured":"Liu Q-W, Li J-Y, Zhang X, Liu Y, Liu Q-Y, Xiao L, Zhang W-J, Wu H-Y, Deng K-Y, Xin H-B. Human amniotic mesenchymal stem cells inhibit hepatocellular carcinoma in tumour?bearing mice. J Cell Mol Med. 2020;24:10525\u201341.","journal-title":"J Cell Mol Med"},{"key":"6133_CR47","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3892\/ijo.2014.2287","volume":"44","author":"A Suetens","year":"2014","unstructured":"Suetens A, Moreels M, Quintens R, Chiriotti S, Tabury K, Michaux A, Gr\u00e9goire V, Baatout S. Carbon ion irradiation of the human prostate cancer cell line pc3: a whole genome microarray study. Int J Oncol. 2014;44:1056\u201372.","journal-title":"Int J Oncol"},{"key":"6133_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.740452","volume":"11","author":"Y Mei","year":"2021","unstructured":"Mei Y, Li K, Zhang Z, Li M, Yang H, Wang H, Huang X, Li X, Shi S, Yang H. mir-33b-3p acts as a tumor suppressor by targeting dock4 in prostate cancer. Front Oncol. 2021;11: 740452.","journal-title":"Front Oncol."},{"issue":"3","key":"6133_CR49","first-page":"2584","volume":"18","author":"Y Liu","year":"2019","unstructured":"Liu Y, Wang J, Yang T, Liu R, Xu Y. Overexpression levels of cripto-1 predict poor prognosis in patients with prostate cancer following radical prostatectomy. Oncol Lett. 2019;18(3):2584\u201391.","journal-title":"Oncol Lett."},{"key":"6133_CR50","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2019.12.025","volume":"473","author":"J Ray","year":"2019","unstructured":"Ray J, Haughey C, Hoey C, Jeon J, Murphy RG, Dura-Perez L, Mccabe N, Downes MR, Jain S, Boutros PC, Mills IG, Liu SK. mir-191 promotes radiation resistance of prostate cancer through interaction with rxra. Cancer Lett. 2019;473:107\u201317.","journal-title":"Cancer Lett"},{"key":"6133_CR51","doi-asserted-by":"publisher","first-page":"98117","DOI":"10.18632\/oncotarget.20981","volume":"8","author":"X Liu","year":"2017","unstructured":"Liu X, Chen L, Huang H, Lv J, Chen M, Qu F-J, Pan X-W, Li L, Yin L, Cui X-G, Gao Y, Xu D. High expression of pdlim5 facilitates cell tumorigenesis and migration by maintaining ampk activation in prostate cancer. Oncotarget. 2017;8:98117\u201334.","journal-title":"Oncotarget"},{"key":"6133_CR52","doi-asserted-by":"publisher","first-page":"1066118","DOI":"10.3389\/fgene.2022.1066118","volume":"13","author":"T Shinawi","year":"2022","unstructured":"Shinawi T, Nasser KK, Moradi FA, Mujalli A, Albaqami WF, Almukadi HS, Elango R, Shaik NA, Banaganapalli B. A comparative mrna- and mirna transcriptomics reveals novel molecular signatures associated with metastatic prostate cancers. Front Genet. 2022;13:1066118.","journal-title":"Front Genet."},{"key":"6133_CR53","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1479-5876-11-111","volume":"11","author":"L Mao","year":"2013","unstructured":"Mao L, Yang C-H, Wang J-Q, Li W, Wen R, Chen J-C, Zheng J. Satb1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion. J Transl Med. 2013;11:111\u2013111.","journal-title":"J Transl Med"},{"issue":"2","key":"6133_CR54","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1021\/pr2006473","volume":"11","author":"FH Jansen","year":"2012","unstructured":"Jansen FH, Rijswijk AL, Teubel WJ, Weerden WM, Reneman S, Bemd G-J, Roobol MJ, Bangma CH, Staal FJT, Jenster GW. Profiling of antibody production against xenograft-released proteins by protein microarrays discovers prostate cancer markers. J Proteome Res. 2012;11(2):728\u201335.","journal-title":"J Proteome Res"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-025-06133-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-025-06133-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-025-06133-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T14:03:02Z","timestamp":1749045782000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-025-06133-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6133"],"URL":"https:\/\/doi.org\/10.1186\/s12859-025-06133-0","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No conflict of interest is declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}